Search results

ANSTO research focuses on an advanced form of cancer treatment under consideration in Australia.

ANSTO uses its infrastructure, capabilities and expertise to build knowledge and optimise the beneficial impacts of nuclear science on human health.

ANSTO is a registered Research Service Provider (RSP), registration number 12657, under section 29A of the Industry Research and Development Act 1986.

ANSTO part of consortium funded by Federal Government to develop new radioimmunological drugs.

ANSTO Nuclear Fuel Cycle researcher recognised for contributions to crystallography and structural chemistry on actinides and lanthanides.

Multi-million dollar Australian Cancer Research Foundation (ACRF) Detector launched at the Australian Synchrotron,

Insights about Mayan Empire relevant for current climate challenges

The proof of concept for the approach used in the early development of the new gamma-ray imaging system has been published,

Explore our new resource, a digital map that highlights our research projects that support the First Nations people of Australia.

Radioactive phosphorous for implantable medical device to treat pancreatic cancer in global clinical trial

Dr Andrew Smith has just finished collecting ice cores and snow samples on the summit of Law Dome in Antarctica,

New high energy ion microprobe beamline supports space research on the effects of radiation on astronauts.